Hans Timmerman

Dr. Hans Timmerman

Department of Anesthesiology, Pain center. University Medical Center Groningen
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2020 in Journal of Neural Transmission
Verified
Journal Article
Open access
PDF file
DRDaniela C. Rosenberger
Daniela C. Rosenberger
VBVivian Blechschmidt
Vivian Blechschmidt
HTHans Timmerman
Hans Timmerman
AWAndré Wolff
André Wolff
RTRolf-Detlef Treede
Rolf-Detlef Treede
Neuropathic pain is a frequent condition caused by a lesion or disease of the central or peripheral somatosensory nervous system. A frequent cause of peripheral neuropathic pain is diabetic neuropathy. Its complex pathophysiology is not yet fully elucidated, which contributes to underassessment and undertreatment. A mechanism-based treatment of painful diabetic neuropathy is challenging but phenotype-based stratification might be a way to develop individualized therapeutic concepts. Our goal is to review current knowledge of the pathophysiology of peripheral neuropathic pain, particularly painful diabetic neuropathy. We discuss state-of-the-art clinical assessment, validity of diagnostic and screening tools, and recommendations for the management of diabetic neuropathic pain including approaches towards personalized pain management. We also propose a research agenda for translational research including patient stratification for clinical trials and improved preclinical models in relation to current knowledge of underlying mechanisms.

1 April 2013 in Physical Therapy
Verified
Journal Article
Open access
PDF file
IHInge E.P.M. van Haren
Inge E.P.M. van Haren
HTHans Timmerman
Hans Timmerman
CPCarin M. Potting
Carin M. Potting
NBNicole M.A. Blijlevens
Nicole M.A. Blijlevens
JSJ. Bart Staal
J. Bart Staal
RSRia Nijhuis-van der Sanden
Ria Nijhuis-van der Sanden
Background: The treatment-related burden for patients undergoing hematopoietic stem cell transplantation (HSCT) may be relieved by physical exercises. Purpose: The purpose of this study was to summarize and analyze the evidence provided by randomized controlled trials (RCTs) on physical exercise interventions among patients with cancer undergoing HSCT. Data Sources: PubMed, CINAHL, EMBASE, the Cochrane Library, and PEDro were searched for relevant RCTs up to October 1, 2011. Study Selection: Two reviewers screened articles on inclusion criteria and indentified relevant RCTs. Data Extraction: Two authors assessed the selected articles for risk of bias. Data extraction was performed by 1 reviewer. Meta-analyses were undertaken to estimate the outcomes quality of life (QOL), psychological well-being and distress, and fatigue. Data Synthesis: Eleven studies were included, with study populations consisting of recipients undergoing either an allogeneic or autologous HSCT (n=734). Four studies had low risk of bias. The exercise interventions were performed before, during, and after hospitalization for the HSCT. Different exercise programs on endurance, resistance and/or activities of daily living training, progressive relaxation, and stretching were used. Meta-analyses showed that exercise during hospitalization led to a higher QOL (weighted mean difference=8.72, 95% confidence interval=3.13, 14.31) and less fatigue (standardized mean difference=0.53, 95% confidence interval=0.16, 0.91) in patients with an allogeneic HSCT at the moment of discharge from the hospital. No marked effects were found for psychological well-being and distress. Individual study results suggested significant positive effects on QOL, fatigue, psychological well-being and distress, and physical functioning. Limitations: Prevalent shortcomings in the included studies were the heterogeneity among studies and the lack of blinding of participants, personnel, and outcome assessment. Conclusions: The results suggest that recipients of HSCT may benefit from physical exercise.

17 December 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ISIngrid Schuttert
Ingrid Schuttert
HTHans Timmerman
Hans Timmerman
KPKristian K. Petersen
Kristian K. Petersen
Megan McPheeMegan McPhee
Megan McPhee
LALars Arendt-Nielsen
Lars Arendt-Nielsen
AWAndré P. Wolff
André P. Wolff
Central sensitisation is assumed to be one of the underlying mechanisms for chronic low back pain. Because central sensitisation is not directly assessable in humans, the term ‘human assumed central sensitisation’ (HACS) is suggested. The objectives were to investigate what definitions for HACS have been used, to evaluate the methods to assess HACS, to assess the validity of those methods, and to estimate the prevalence of HACS. Database search resulted in 34 included studies. Forty different definition references were used to define HACS. This review uncovered twenty quantitative methods to assess HACS, including four questionnaires and sixteen quantitative sensory testing measures. The prevalence of HACS in patients with chronic low back pain was estimated in three studies. The current systematic review highlights that multiple definitions, assessment methods, and prevalence estimates are stated in the literature regarding HACS in patients with chronic low back pain. Most of the assessment methods of HACS are not validated but have been tested for reliability and repeatability. Given the lack of a gold standard to assess HACS, an initial grading system is proposed to standardize clinical and research assessments of HACS in patients with a chronic low back.

30 November 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
HTHans Timmerman
Hans Timmerman
MSMonique A H Steegers
Monique A H Steegers
FHFrank J P M Huygen
Frank J P M Huygen
JGJelle J Goeman
Jelle J Goeman
NDNick T Van Dasselaar
Nick T Van Dasselaar
KVKris C P Vissers
Kris C P Vissers
Neuropathic pain is clinically described as pain caused by a lesion or disease of the somatosensory nervous system. The aim of this study was to assess the validity of the Dutch version of the DN4, in a cross-sectional multicentre design, as a screening tool for detecting a neuropathic pain component in a large consecutive, not pre-stratified on basis of the target outcome, population of patients with chronic pain. Patients’ pain was classified by two independent (pain-)physicians as the gold standard. The analysis was initially performed on the outcomes of those patients (n = 228 out of 291) in whom both physicians agreed in their pain classification. Compared to the gold standard the DN4 had a sensitivity of 75% and specificity of 76%. The DN4-symptoms (seven interview items) solely resulted in a sensitivity of 70% and a specificity of 67%. For the DN4-signs (three examination items) it was respectively 75% and 75%. In conclusion, because it seems that the DN4 helps to identify a neuropathic pain component in a consecutive population of patients with chronic pain in a moderate way, a comprehensive (physical-) examination by the physician is still obligate.

8 August 2010 in Physiotherapy Theory and Practice
Verified
Journal Article
Closed access
HTHans Timmerman
Hans Timmerman
JGJ F de Groot
J F de Groot
HHH J Hulzebos
H J Hulzebos
RKR de Knikker
R de Knikker
HKH E M Kerkkamp
H E M Kerkkamp
NMN L U van Meeteren
N L U van Meeteren
The aim of this pilot study is to determine the feasibility and preliminary effectiveness of an individually designed preoperative therapeutic exercise program (PreTEP), in patients recently diagnosed with cancer and awaiting elective surgery. The purpose is to improve their physical fitness levels during this waiting period with the intention of decreasing postoperative morbidity. A preexperimental pilot study was performed at the University Medical Center Utrecht, The Netherlands. Thirty-nine patients diagnosed with cancer, scheduled for elective abdominal/thoracic surgery, were referred to a multidisciplinary preoperative screening. Fifteen patients (38%) participated in PreTEP. Participants were satisfied and motivated during the period of training (on average 5 weeks) in which they attended 84% of the sessions. Cardiorespiratory fitness (A strand-test) and muscle strength (Handheld Dynamometry) increased significantly, from 25 to 33 mL/kg/min, respectively (p<0.01; 95% confidence interval [CI]=-0.011 to -0.004) and from 894 Newton (N) to 961N (p<0.01; 95% CI=-94.53 to -39.0). No adverse events occurred during the training period. PreTEP was shown to be feasible, safe, and well-tolerated and appreciated by participants. Despite the relatively short period of training, physical fitness improved in all participants.

9 July 2012 in Pain Practice
Verified
Journal Article
Closed access
PDF file
HTHans Timmerman
Hans Timmerman
AWAndré P. Wolff
André P. Wolff
TSTobias Schreyer
Tobias Schreyer
JOJacqueline Outermans
Jacqueline Outermans
AEAndrea W.M. Evers
Andrea W.M. Evers
KVKris. C. P. Vissers
Kris. C. P. Vissers